Picture EBD Group BIO-Europe Spring 2025 Milan to 14 Mar 650x100px

Document › Details

Nanoform Finland Oyj. (3/9/21). "Press Release: Nanoform Finland Plc Announces Its Intention to Carry Out a New Share Issue to Raise approximately EUR 40 Million [ Not for US, CA, NZ, AU, et al.]".

	Organisation	Nanoform Finland Oyj
	Group	Nanoform (Group)
	Organisation 2	Nasdaq First North Growth Market
	Group	Nasdaq OMX (Group)
	Product	Controlled Expansion of Supercritical Solutions (CESS™) technology
	Product 2	investment banking
	Index term	Nanoform–SEVERAL: investment, 202103 directed placing €40m with 5.634m new shares at €7.1/share to institution + qualified investors with 7% discount
	Person	Hæggström, Albert (Nanoform 201907 CFO)
	Person 2	von Haartman, Henri (Nanoform 201907– Director Investor Relations)

Original document
accessed by [iito] on 2021-08-17

Record changed: 2023-06-05

Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x200px

More documents for Nanoform (Group)

[1] Nanoform Finland Oyj. (10/23/23). "Press Release: Nanoform Grant Global Starmap AI License to AstraZeneca". Helsinki....
[2] Nanoform Finland Oyj. (8/17/21). "Press Release: Nanoform and Boehringer Ingelheim Execute Master Services Agreement". Munich....
[3] Nanoform Finland Oyj. (3/9/21). "Press Release: Nanoform Finland Plc Successfully Completes New Share Issue Raising EUR 40 million [ Not for US, CA, NZ, AU, et al.]"....
[4] Nanoform Finland Oyj. (2/10/20). "Press Release: Nanoform Establishes US Subsidiary". Helsinki....
[5] Coulter Partners. (1/21/20). "Press Release: Coulter Partners Secures Head of US Sales for Nanoform"....
[6] Nanoform Finland Oyj. (1/13/20). "Press Release: Nanoform Appoints Head of US Sales". Helsinki....
[7] Nanoform Finland Oyj. (7/10/19). "Press Release: Nanoform Appoints Director of Investor Relations Following International Growth". Helsinki....
[8] Nanoform Finland Oyj. (7/3/19). "Press Release: Nanoform Continues Strategic Growth with €10 Million Private Placement". Helsinki....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]